Clinical Trials Directory

Trials / Completed

CompletedNCT05481593

An Accessible and Inclusive Artificial Intelligence Assisted Chronic Disease Self-Management Telehealth Platform

An Accessible and Inclusive Artificial Intelligence Assisted Chronic Disease Self-Management Telehealth Platform: A Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
212 (actual)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study to pilot test an accessible and inclusive artificial intelligence (AI)-assisted, individualized, family-focused lifestyle modification intervention (AI4CHRON) for health-related quality of life for adults with impaired mobility and chronic medical conditions.

Detailed description

The AI4CHRON study will use a four-arm randomized control trial design. Eligible and consented participants will be assigned to one of four groups: 1) Scheduled coaching calls with gamified rewards, 2) Scheduled coaching calls with rewards independent of gamification, 3) No scheduled coaching calls with gamified rewards, and 4) No scheduled coaching calls with rewards independent of gamification. The active intervention period will be six months.

Conditions

Interventions

TypeNameDescription
BEHAVIORALScheduled Coaching + Gamified RewardsParticipants will receive scheduled coaching calls and receive gamified rewards (i.e., earning points over time and converted to monetary gifts)
BEHAVIORALScheduled Coaching Calls + Independent RewardsParticipants will receive scheduled coaching calls and receive fixed rewards (i.e., non-increasing)
BEHAVIORALNo Scheduled Coaching Calls + Gamified RewardsParticipants will not have scheduled coaching calls and receive gamified rewards (i.e., earning points over time and converted to monetary gifts)
BEHAVIORALNo Scheduled Coaching Calls + Independent rewardsParticipants will not have scheduled coaching calls and receive fixed rewards (i.e., non-increasing)

Timeline

Start date
2024-02-01
Primary completion
2025-10-31
Completion
2025-10-31
First posted
2022-08-01
Last updated
2025-12-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05481593. Inclusion in this directory is not an endorsement.